IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis

Journal of Leukocyte Biology

Volumn 83, Issue 2, 2008, Pages 361-367

  Antonopoulos, Christos ^a   Cumberbatch, Marie ^b   Mee, John B ^a   Dearman, Rebecca J ^b   Wei, Xiao Qing ^c   Liew, Foo Y ^d   Kimber, Ian ^b   Groves, Richard W ^a,e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e GUY S HOSPITAL   (United Kingdom)

Author keywords

Caspase 1; Lymph nodes; Oxazolone

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; INTERLEUKIN 18 BINDING PROTEIN; OXAZOLONE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTACT ALLERGY; CONTACT DERMATITIS; EPIDERMIS; INFLAMMATION; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

ANIMALS; CASPASE 1; CELL COUNT; CELL MOVEMENT; DERMATITIS, ALLERGIC CONTACT; DINITROFLUOROBENZENE; EPIDERMIS; INTERLEUKIN-18; INTERLEUKIN-1BETA; LANGERHANS CELLS; MICE; MICE, KNOCKOUT; OXAZOLONE; RECOMBINANT PROTEINS; SODIUM DODECYL SULFATE; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS;

EID: 38949124339     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0604352     Document Type: Article

References (42)

1. Stingl, G., Katz, S. I., Green, I., Shevach, E. M. (1980) The functional role of Langerhans cells. J. Invest. Dermatol. 74, 315-318.
2. Wolff, K., Stingl, G. (1983) The Langerhans cell. J. Invest. Dermatol. 80 (Suppl.), 17s-21s.
3. Griffiths, C. E., Dearman, R. J., Cumberbatch, M., Kimber, I. (2005) Cytokines and Langerhans cell mobilization in mouse and man. Cytokine 32, 67-70.
4. Cumberbatch, M., Dearman, R. J., Kimber, I. (1997) Interleukin 1β and the stimulation of Langerhans cell migration: comparisons with tumor necrosis factor α. Arch. Dermatol. Res. 289, 277-284.
5. Cumberbatch, M., Dearman, R. J., Kimber, I. (1997) Langerhans cells require signals from both tumor necrosis factor-α and interleukin-1β for migration. Immunology 92, 388-395.
6. Cumberbatch, M., Griffiths, C. E., Tucker, S. C., Dearman, R. J., Kimber, I. (1999) Tumor necrosis factor-α induces Langerhans cell migration in humans. Br. J. Dermatol. 141, 192-200.
7. Enk, A. H., Angeloni, V. L., Udey, M. C., Katz, S. I. (1993) An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J. Immunol. 150, 3698-3704.
8. Antonopoulos, C., Cumberbatch, M., Dearman, R. J., Daniel, R. J., Kimber, I., Groves, R. W. (2001) Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J. Immunol. 166, 3672-3677.
9. Cumberbatch, M., Dearman, R. J., Antonopoulos, C., Groves, R. W., Kimber, I. (2001) Interleukin (IL)-18 induces Langerhans cell migration by a tumor necrosis factor-α- and IL-1β-dependent mechanism. Immunology 102, 323-330.
10. Wang, B., Feliciani, C., Howell, B. G., Freed, I., Cai, Q., Watanabe, H., Sauder, D. N. (2002) Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity. J. Immunol. 168, 3303-3308.
11. Gutzmer, R., Langer, K., Mommert, S., Wittmann, M., Kapp, A., Werfel, T. (2003) Human dendritic cells express the IL-18R and are chemoattracted to IL-18. J. Immunol. 171, 6363-6371.
12. Wei, X. Q., Leung, B. P., Niedbala, W., Piedrafita, D., Feng, G. J., Sweet, M., Dobbie, L., Smith, A. J., Liew, F. Y. (1999) Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J. Immunol. 163, 2821-2828.
13. Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., et al. (1995) Mice deficient in IL-1 β-converting enzyme are defective in production of mature IL-1 β and resistant to endotoxic shock. Cell 80, 401-411.
14. Li, P., Allen, H., Banerjee, S., Seshadri, T. (1997) Characterization of mice deficient in interleukin-1 β converting enzyme. J. Cell. Biochem. 64, 27-32.
15. Dinarello, C. A. (2007) Interleukin-18 and the pathogenesis of inflammatory diseases. Semin. Nephrol. 27, 98-114.
16. Fantuzzi, G., Dinarello, C. A. (1999) Interleukin-18 and interleukin-1 β: two cytokine substrates for ICE (caspase-1). J. Clin. Immunol. 19, 1-11.
17. Mee, J. B., Alam, Y., Groves, R. W. (2000) Human keratinocytes constitutively produce but do not process interleukin-18. Br. J. Dermatol. 143, 330-336.
18. Ariizumi, K., Kitajima, T., Bergstresser, O. R., Takashima, A. (1995) Interleukin-1 β converting enzyme in murine Langerhans cells and epidermal-derived dendritic cell lines. Eur. J. Immunol. 25, 2137-2141.
19. Stoll, S., Jonuleit, H., Schmitt, E., Muller, G., Yamauchi, H., Kurimoto, M., Knop, J., Enk, A. H. (1998) Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur. J. Immunol. 28, 3231-3239.
20. Tsutsui, H., Kayagaki, N., Kuida, K., Nakano, H., Hayashi, N., Takeda, K., Matsui, K., Kashiwamura, S., Hada, T., Akira, S., et al. (1999) Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 11, 359-367.
21. Gutierrez-Steil, C., Wrone-Smith, T., Sun, X., Krueger, J. G., Coven, T., Nickoloff, B. J. (1998) Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J. Clin. Invest. 101, 33-39.
22. Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J. H., Tschopp, J., French, L. E. (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282, 490-493.
23. Konishi, H., Tsutsui, H., Murakami, T., Yumikura-Futatsugi, S., Yamanaka, K., Tanaka, M., Iwakura, Y., Suzuki, N., Takeda, K., Akira, S., et al. (2002) IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc. Natl. Acad. Sci. USA 99, 11340-11345.
24. Plitz, T., Saint-Mezard, P., Satho, M., Herren, S., Waltzinger, C., de Carvalho Bittencourt, M., Kosco-Vilbois, M. H., Chvatchko, Y. (2003) IL-18 binding protein protects against contact hypersensitivity. J. Immunol. 171, 1164-1171.
25. Cumberbatch, M., Dearman, R. J., Kimber, I. (1999) Langerhans cell migration in mice requires intact type I interleukin 1 receptor (IL-1RI) function. Arch. Dermatol. Res. 291, 357-361.
26. Cumberbatch, M., Fielding, I., Kimber, I. (1994) Modulation of epidermal Langerhans' cell frequency by tumor necrosis factor-α. Immunology 81, 395-401.
27. Cumberbatch, M., Dearman, R. J., Kimber, I. (1998) Characteristics and regulation of the expression on interleukin 1 receptors by murine Langerhans cells and keratinocytes. Arch. Dermatol. Res. 290, 688-695.
28. Wang, B., Fujisawa, H., Zhuang, L., Kondo, S., Shivji, G. M., Kim, C. S., Mak, T. W., Sauder, D. N. (1997) Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J. Immunol. 159, 6148-6155.
29. Dinarello, C. A. (2001) Anti-cytokine therapies in response to systemic infection. J. Investig. Dermatol. Symp. Proc. 6, 244-250.
30. Koizumi, H., Sato-Matsumura, K. C., Nakamura, H., Shida, K., Kikkawa, S., Matsumoto, M., Toyoshima, K., Seya, T. (2001) Distribution of IL-18 and IL-18 receptor in human skin: various forms of IL-18 are produced in keratinocytes. Arch. Dermatol. Res. 293, 325-333.
31. Wittmann, M., Purwar, R., Hartmann, C., Gutzmer, R., Werfel, T. (2005) Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases. J. Invest. Dermatol. 124, 1225-1233.
32. Stober, D., Schirmbeck, R., Reimann, J. (2001) IL-12/IL-18-dependent IFN- release by murine dendritic cells. J. Immunol. 167, 957-965.
33. Suto, H., Nakae, S., Kakurai, M., Sedgwick, J. D., Tsai, M., Galli, S. J. (2006) Mast cell-associated TNF promotes dendritic cell migration. J. Immunol. 176, 4102-4112.
34. Netea, M. G., Kullberg, B. J., Verschueren, I., Van Der Meer, J. W. (2000) Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1β. Eur. J. Immunol. 30, 3057-3060.
35. Puren, A. J., Fantuzzi, G., Gu, Y., Su, M. S., Dinarello, C. A. (1998) Interleukin-18 (IFN-inducing factor) induces IL-8 and IL-1β via TNFα production from non-CD14+ human blood mononuclear cells. J. Clin. Invest. 101, 711-721.
36. Kupper, T. S., Groves, R. W. (1995) The interleukin-1 axis and cutaneous inflammation. J. Invest. Dermatol. 105, 62S-66S.
37. Morel, J. C., Park, C. C., Woods, J. M., Koch, A. E. (2001) A novel role for interleukin-18 in adhesion molecule induction through NF κ B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways. J. Biol. Chem. 276, 37069-37075.
38. Cumberbatch, M., Dearman, R. J., Groves, R. W., Antonopoulos, C., Kimber, I. (2002) Differential regulation of epidermal Langerhans cell migration by interleukins (IL)-1α and IL-1β during irritant- and allergen-induced cutaneous immune responses. Toxicol. Appl. Pharmacol. 182, 126-135.
39. Cho, Y. S., Kang, J. W., Cho, M., Cho, C. W., Lee, S., Choe, Y. K., Kim, Y., Choi, I., Park, S. N., Kim, S., Dinarello, C. A., Yoon, D. Y. (2001) Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18. FEBS Lett. 501, 139-145.
40. Lee, S. J., Cho, Y. S., Cho, M. C., Shim, J. H., Lee, K. A., Ko, K. K., Choe, Y. K., Park, S. N., Hoshino, T., Kim, S., et al. (2001) Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-γ production in human peripheral blood mononuclear and NK cells. J. Immunol. 167, 497-504.
41. Smith, V. P., Bryant, N. A., Alcami, A. (2000) Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. J. Gen. Virol. 81, 1223-1230.
42. Xiang, Y., Moss, B. (2003) Molluscum contagiosum virus interleukin-18 (IL-18) binding protein is secreted as a full-length form that binds cell surface glycosaminoglycans through the C-terminal tail and a furincleaved form with only the IL-18 binding domain. J. Virol. 77, 2623-2630.